Greater China
Invesco leads $155m round for China's Brii Biosciences
Invesco has led a $155 million Series C round for China-focused infectious diseases drug developer Brii Biosciences.
CMB, Mirae lead Series C for China biotech player EpimAb
Shanghai-based EpimAb Biotherapeutics has raised $120 million in Series C funding led by CMB International and Korea’s Mirae Asset Financial Group.
China drug development outsourcer raises $70m
Zhenge Biotech – a Shanghai-based contract development and manufacturing organization (CDMO) for large molecule drugs – has raised $70 million in Series B funding led by Qiming Venture Partners and IDG Capital.
China's Taishan Beer raises $92m
CMC Capital Group has committed RMB600 million ($92 million) in funding to Chinese domestic beer brand Taishan.
China direct lending: Creative credit
A combination of improved collateral, rising yields and robust demand is drawing investors to China’s direct lending space. Opportunities abound, but local execution remains critical
Ares & SSG: Scale proposition
The merger of Ares Management and SSG Capital is among the largest ever seen in Asian alternatives. They are now pushing into new markets and segments, leveraging the combination of size and local resources
Private equity & credit: Seeking synergies
GPs are placing greater emphasis on Asia private debt strategies to capture deals that don’t work as private equity. Much can be achieved by pooling ideas and resources, but collaboration isn’t as straightforward as it seems
Bain backs China gas station platform Newlink
Bain Capital Private Equity led a $200 million investment in Newlink Group, operator of a platform that helps drivers in China locate the best value gas stations and charging piles. Joy Capital re-upped in the round.
Brookfield hires ex-Blackstone executive to lead China PE
Alex Yang, formerly a senior managing director at The Blackstone Group, has been recruited by Brookfield Asset Management to lead its private equity business in China.
China's Connect Biopharma gains 8% on debut after $191m US IPO
Connect Biopharma, a China-headquartered drug developer specializing in treatments for T cell-driven inflammatory diseases, gained 8.8% on debut following a $191.3 million US IPO.
China autonomous driving developer Momenta raises $500m
SAIC Motor, Toyota Motor Corporation, Robert Bosch, Yunfeng Capital, and Temasek Holdings are among the investors in a $500 million Series C funding round for Chinese autonomous driving technology developer Momenta.
China cybersecurity player ThreatBook raises $77m
Beijing-based cybersecurity solutions provider ThreatBook has completed a RMB500 million ($77 million) Series E round led by CPE and featuring existing investor V Fund.
China's Tuya completes $915m IPO, gains on debut
Tuya, a Chinese start-up that claims to be the world’s largest platform-as-a-service (PaaS) provider in terms of number of smart devices powered, raised $915.4 million in its US IPO. The offering was priced above the indicative range yet still registered...
China's GSR Ventures appoints first female managing director
Yutong Zhang has become the first woman to join the team of managing directors that leads Chinse VC firm GSR Ventures.
Hong Kong's Gly Capital launches $300m mobility tech fund
Gly Capital, a Hong Kong-based investor controlled by Chinese auto giant Geely, has launched a $300 million mobility tech fund.
Temasek leads round for China marketing content start-up
Tezign, a Chinese start-up that serves as a content-focused one-stop marketing solutions platform, has closed a second tranche of Series C funding that takes the overall total for the round to $100 million.
China biotech makes Asia global healthcare PE leader
A more than 100% year-on-year increase in deal volume saw Asia Pacific overtake North America to become the most active global private equity healthcare market for the first time in 2020.
China's B2B trading platform Ichunt raises $100m
Ichunt.com, a Chinese B2B trading platform for electronic components, has raised nearly $100 million in Series C funding from JD MRO, the industrial supplies business of local e-commerce giant JD.com.
CMB, Tiantu lead $300m Series D for China's Guoquan
Guoquan, a Chinese hot pot ingredients supplier, has raised a $300 million Series D round led by CMB International and Tiantu Capital.
China agricultural drone maker XAG raises $46m
XAG, a Chinese manufacturer of agricultural drones, has raised RMB300 million ($46 million) in funding from GL Ventures.
CITIC Capital rebrands as Trustar, backs Swiss medtech business
CITIC Capital Partners, a private equity firm part-owned by Chinese conglomerate CITIC Group, has rebranded as Trustar Capital.
Hillhouse, Tencent lead Series C for China's Fenbeitong
Hillhouse Capital and Tencent Holdings have led a $92.5 million Series C round for Fenbeitong, a China-based enterprise payment and expense management software provider.
China VC player Source Code to raise $1b
Source Code Capital, a Chinese venture capital firm founded by Yi Cao (pictured), formerly of Sequoia Capital China, is set to raise $1 billion across two funds.
Deal focus: MetaApp’s supply-demand solution
China-based MetaApp has created an online platform that connects games with relevant gamers. Community building and social interaction are its watchwords
